MONTREAL, Dec. 2 /CNW Telbec/ - ZoomMed Inc. ("ZoomMed"), TSX Venture:
ZMD. M. Yves Marmet, President and Chief Executive Officer, announced on
November 24, 2005 that the corporation has filed a preliminary prospectus on
November 8, 2005 with "les AutoritDes des MarchDes Financiers" in Quebec and
Ontario.
A minimum of 3,750,000 Common Shares of the Corporation and a maximum of
12,500,000 Common Shares of the Corporation are being offered under this
prospectus at a price of $0.20 per Common Share for minimum gross proceeds of
$750,000 and maximum gross proceeds of $2,500,000.
Furthermore, ZoomMed has obtained, on November 22, 2005, an advance
income tax ruling from the "MinistGere du Revenu du QuDebec" in order to confirm
that the Common Shares of ZoomMed to be issued pursuant to this Offering will
be eligible shares, upon issuance, for inclusion in an SME Growth Stock Plan
in accordance with the announcements contained in the Additional Information
on the Budgetary Measures of the 2005-2006 Budget tabled on April 21, 2005 and
the current provisions of the Taxation Act (QuDebec), subject to certain
conditions contained thereunder.
ZoomMed is presently developing a new electronic tool "ZRx Prescriber",
intended to change the way drugs are prescribed and dispensed throughout
Canada. This handheld prescribing system device, equipped with tools such as a
therapeutic advisor as well as a medication interaction manager, will enable
doctors to fill prescriptions and to electronically transmit them in a fast
and secure mode. This user friendly Web product, designed for doctors, will
use the latest "Pocket PC" technologies.
ZoomMed Inc. files its financial statements, press releases and other
required filing documents on the SEDAR data base at www.sedar.com.
The preliminary prospectus is subject to approval by "les AutoritDes des
MarchDes financiers".
The TSX Venture Exchange has neither approved nor accepts any
responsibility with respect to the veracity or exactitude of this press
release.
%SEDAR: 00021870EF
Zoommed: Common Share offering eligible for inclusion in an SME Growth Stock Plan
On 6ix: 6ix.com/news/zoommed-common-share-offering-eligible-for-inclusion-in-an-sme-growth-stock-plan
Story so far
Earlier from ZoomMed
- ZoomMed has filed a preliminary prospectus and an application for inclusion in an SME Growth Stock Plan.
- Following the Annual Shareholders Meeting, ZoomMed presents its Board of Directors and the officers of the corporation
- ZoomMed is now trading on the TSX-Venture
Later from ZoomMed
- ZoomMed announces the filing of a final prospectus
- ZoomMed announces the filing of an amended and restated prospectus
- ZoomMed announces the closing of an offering
- ZoomMed announces the second closing of an offering
- ZoomMed signs a commercial collaboration agreement with ADN Medical
Follow ZoomMed into a list and get an email when it puts out news.
Follow ZoomMed